Navigation

2003/004 Following planned review NICE issues updated guidance on paclitaxel for ovarian cancer

Following a review of its previous guidance and consideration of new evidence the National Institute for Clinical Excellence has updated its guidance on paclitaxel for ovarian cancer.

This page was last updated: 30 April 2009

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.